ADDITIONAL INFO

RAD‑140 (Testolone) — Selective Androgen Receptor Modulator Research Compound

RAD‑140 (Testolone) is a non-steroidal selective androgen receptor modulator (SARM) engineered for high affinity and specificity toward androgen receptors (ARs). It demonstrates tissue-selective activity, targeting androgenic signaling pathways while minimizing off-target effects. Researchers use RAD‑140 in in-vitro and preclinical studies to investigate muscle maintenance, anabolic signaling, and receptor-specific transcriptional activity.

For in‑vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.

Product Details

Compound Name: RAD‑140 (Testolone)
Net Contents: 20 mg/mL sublingual dropper or 10 mg capsules
Purity: ≥98% (HPLC tested; Certificate of Analysis available)
Primary Targets: Androgen receptors in skeletal muscle and bone, anabolic signaling pathways
Manufactured in: GMP-compliant facility
Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed at −20 °C, protected from light and moisture

• Short-term storage: 2–8 °C in sealed vials

• Allow vial to reach room temperature before opening

• Reconstitute under sterile conditions using appropriate buffers

• Avoid repeated freeze–thaw cycles

• Consult SDS for safety and handling guidance

Research Applications

RAD‑140 is commonly used in laboratory and preclinical studies to investigate:

• Activation of androgen receptors in skeletal muscle and bone

• Muscle maintenance and prevention of catabolic pathways

• Bone health and metabolic signaling

• Receptor-specific transcriptional activity

• Preclinical models of anabolic signaling and muscle preservation